WHEN one undertakes the treatment of a patient suffering from ulcerative colitis with the steroid group of substances, it is important to know if this is likely to prejudice success if operation becomes necessary later. Many clinicians fear the possibilities of wound infection, delayed healing, adrenal failure, and the contingency that steroids may make the colitis worse.
reported 3 cases of ulcerative colitis with advanced and extensive disease whose colons, adherent to other viscera and the parietes, disintegrated on handling at operation; he considered that this condition was probably due to prolonged steroid treatment before operation. At the Gordon Hospital, too, our surgeons have been called upon to operate on many desperately ill patients who have failed to respond to steroid treatment elsewhere; the technical difficulties in these have been great, the post-operative course has been stormy, and some have died. It has been tempting to attribute the bad condition and results in these poor-risk cases to the antecedent steroid therapy, until one recalls that ulcerative colitis was emphatically a dangerous, and indeed often fatal, disease long before steroids were introduced.
If one were able to compare the operative findings and post-operative course in patients who had never received steroids with those in patients who had received such treatment pre-operatively, in the same hospital, during the same period and operated on by the same surgeons, it would be possible to decide whether this form of treatment had adversely affected the final outcome. No specific indications or contraindications are known for the use of steroids in the treatment of colitis, although co-existing conditions such as diabetes mellitus, or peptic ulcer, may make their use inadvisable. For this reason such a study may have almost the validity of a controlled trial with random selection of patients for the "steroid" and "no steroid" groups. This paper consists of such a comparison, avoiding, however, the method of historical controls used by Maltby et al. (1956) and Goldgraber et al. (1957) .
The material is composed of the patients who registered at the Gordon Hospital during the five-year period 1954-1958 inclusive, who were operated on at the Gordon, or treated by us with steroids, or both. Before 1954 we encountered no steroid-treated cases.
'From the Gordon Hospital, London.
The first part of this report is an attempt to assess the promptness of response to steroids. If we know in advance how quickly evidence of improvement ought to appear, then the unresponsive case will be recognized early, and dangerous delay in operating will be avoided.
The drugs we used were ACTH gel, 80 units, 200 mg. cortisone acetate, or 30-40 mg. prednisolone daily for six weeks, or until remission occurred or operation was performed. If hydrocortisone retention enemata were given, these were nightly, usually for fifteen nights, 100 mg. in each enema. Table I shows the number of courses of each steroid given. It shows too that many of those who improved had begun to do so by the eighth day of treatmentapproximately two-thirds of the successful cases had already begun to show clear-cut improvement in this time and, in fact, about one-third did show clearly recognizable improvement before the fourth day, a few being remarkably benefited on the first day. Table II shows what happened to those who did not improve before the eighth day; 60 % never improved, and subsequently 25 % of these had their colons removed.
These results indicate that, provided a patient is not deteriorating on steroid treatment, it is probably reasonable to give steroids in full doses for eight days; if he is no better by this time, and if his disease is severe and extensive enough to warrant colectomy, then it is probably wise to proceed with surgery.
There were 130 patients treated surgically, of whom 62 had received steroid treatment for periods varying from three days to over a year, either at the Gordon Hospital, or elsewhere.
Proceedings of the Royal Society of Medicine 68 never received this form of treatment. The operations, with only one or two exceptions, have been colectomies combined with ileorectal anastomosis either at the same time or in planned stages. Table III shows the proportion of   TABLE III patients in each group whose operations were straightforward and whose convalescence was uncomplicated; the two groups did not differ in this respect. Technical hazards in the course of operation are mainly due to the physical state of the colon, although these are often added to by the poor general condition of the patient. It might be argued that steroids, in some cases at least, do encourage the destructive process in the colon, and for this reason I have compared the frequency with which involvement of the colon severe enough to cause serious operative difficulty was encountered (Table IV) . These distended, friable, adherent, sometimes perforated, and often disintegrating colons have not been met with more often in the steroidtreated patients, and I do not think that we have any evidence that this severe form of the disease has become more frequent as a result of steroid therapy.
The next subject for comparison was wound complications in the post-operative period. Massive doses of steroid substances have been shown in animals to hinder wound-healing, and their anti-inflammatory action might be expected to increase the frequency of infective complications. Table V shows that in practice, although this type of complication was fairly frequent, the frequency was not remarkably different in each group; once more there is nothing to support any hypothesis that failure of wound-healing or post-operative infection is attributable to steroid treatment.
Adrenal insufficiency over the operative period is a possibility which is never far from one's thoughts in the management of these patients. Our cases have had generous cortisone cover for a sevento ten-day period beginning on the day before operation. Nevertheless there have been 3 deaths due to adrenal insufficiency confirmed by post-mortem; one of these was from the no-steroid group whilst 2 out of the 3 post-mortem examinations performed in the steroid series showed adrenal changes. Syndromes suggestive of adrenal insufficiency have frequently been observed in both groups, and between the two groups. It is often impossible to disentangle the various possible causes of these states in a seriously ill patient, but it is worthy of note that several patients who had not received steroids pre-operatively were given hydrocortisone intravenously as part of the resuscitative measures post-operatively and apparently benefited.
Operative mortality is often difficult to interpret. Many of these patients have been "cold" cases, whereas some have been desperately ill. Are the chances of survival in the very ill cases reduced by treatment with steroids? It would seem not, at all events in our series; the operative mortality in the no-steroid group was 16 % whereas it was only 10% in the patients who had received these drugs previously.
After comparing the surgical results in these two almost equal groups, one having had preoperative steroid treatment and the other not, the operations having been carried out by the same surgeons, at the same hospital, over the same five-year period, one now feels reasonably confident at the outset of a course of treatment with cortisone-like substances that one is not taking a course of action which is likely to make a surgeon's task harder if operation later becomes necessary. What we do feel, however, is that now we have a potent (but alas only temporary) remedy for this disease, and that there is a temptation to persevere too long with steroids in the unresponsive case, hoping that eventual improvement will occur. This temptation should be resisted if valuable time-and lives-are not to be lost.
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